Literature DB >> 10401658

A gene therapy approach to accelerating bone healing. Evaluation of gene expression in a New Zealand white rabbit model.

A W Baltzer1, C Lattermann, J D Whalen, S Braunstein, P D Robbins, C H Evans.   

Abstract

It has been demonstrated that BMPs, IGFs, and TGFbetas improve the process of bone healing in vivo. We have suggested the use of gene therapy as a possible way to deliver growth factors to fracture sites in order to improve repair. The aim of this study was to develop a minimally invasive gene therapy approach to treat bone injuries locally without damaging the local blood circulation. A segmental defect of 1.3 cm was created in the diaphysis of the femur in mature NZW rabbits. Internal fixation with 7-hole DCP plates and 2.7 mm screws was used to stabilize the bone. After building a chamber by tightly closing the muscles around the segmental defect, 0.5 ml of either saline solution or a collagen gel containing 1 x 10(10) particles of adenovirus carrying cDNA encoding either the bacterial beta-galactosidase gene (LacZ), or the firefly luciferase gene were injected into the gap. The control side received 0.5 ml of saline solution without virus particles. Bone marrow, cortical and trabecular bone and surrounding muscle were harvested from the injected femur and were analyzed for local gene expression through X-gal staining or measurement of local luciferase activity. To determine whether distant sites were transduced, tissue from the spleen, liver, and lung were harvested as well as bone, bone marrow and muscle from the contralateral diaphysis of the femur. The delivery of the adenoviral vector suspended in saline solution led to local transduction of the bone, bone marrow and the muscle surrounding the gap. No luciferase activity was found in the contralateral femur, lung, or spleen, and only transient luciferase activity was seen in the liver. While marker gene expression persisted within the surrounding soft tissues for at least 2 weeks, the expression in bone lasted up to 6 weeks. This study has shown that it is possible to use adenoviral vectors to transfer and express genes locally within a segmental defect. Gene expression persisted for several weeks, which may be already sufficient to accelerate repair.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401658     DOI: 10.1007/s001670050147

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  17 in total

Review 1.  Recent Advances: Orthopaedics.

Authors:  C G Moran; L J Tourret
Journal:  BMJ       Date:  2001-04-14

2.  Gene transfer to the tendon-bone insertion site.

Authors:  Christian Lattermann; Boris A Zelle; Janey D Whalen; Axel W A Baltzer; Paul D Robbins; Christopher Niyibizi; Christopher H Evans; Freddie H Fu
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2004-03-09       Impact factor: 4.342

3.  Orthopedic gene therapy--lost in translation?

Authors:  C H Evans; S C Ghivizzani; P D Robbins
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 4.  Gene therapy for the regeneration of bone.

Authors:  Christopher Evans
Journal:  Injury       Date:  2011-04-13       Impact factor: 2.586

Review 5.  The potential of gene therapy for fracture healing in osteoporosis.

Authors:  M Egermann; E Schneider; C H Evans; A W Baltzer
Journal:  Osteoporos Int       Date:  2005-01-15       Impact factor: 4.507

6.  Rapid and reliable healing of critical size bone defects with genetically modified sheep muscle.

Authors:  F Liu; E Ferreira; R M Porter; V Glatt; M Schinhan; Z Shen; M A Randolph; C A Kirker-Head; C Wehling; M S Vrahas; C H Evans; J W Wells
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

Review 7.  Using genes to facilitate the endogenous repair and regeneration of orthopaedic tissues.

Authors:  Christopher Evans
Journal:  Int Orthop       Date:  2014-07-20       Impact factor: 3.075

8.  Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage.

Authors:  C H Evans; F-J Liu; V Glatt; J A Hoyland; C Kirker-Head; A Walsh; O Betz; J W Wells; V Betz; R M Porter; F A Saad; L C Gerstenfeld; T A Einhorn; M B Harris; M S Vrahas
Journal:  Eur Cell Mater       Date:  2009-12-31       Impact factor: 3.942

9.  Gene gun transferring-bone morphogenetic protein 2 (BMP-2) gene enhanced bone fracture healing in rabbits.

Authors:  Wenju Li; Haifeng Wei; Chunmei Xia; Xiaomeng Zhu; Guozhu Hou; Feng Xu; Xinghua Song; Yulin Zhan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 10.  Orthopedic gene therapy in 2008.

Authors:  Christopher H Evans; Steven C Ghivizzani; Paul D Robbins
Journal:  Mol Ther       Date:  2008-12-09       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.